A mother's determination to change lives: Jesy Nelson advocates for newborn screening of SMA.
In a heartfelt revelation, singer Jesy Nelson shared that her twin daughters have been diagnosed with Spinal Muscular Atrophy (SMA), a rare and severe muscle disease. This diagnosis has ignited a passionate campaign, as Nelson vows to fight for mandatory testing of all newborns for SMA at birth. But here's the catch: this test is not yet standard practice.
Currently, the NHS offers a blood test for newborns around five days old, screening for ten other conditions, but SMA is not included. Nelson's goal is to change that, ensuring SMA is added to this vital screening process. She believes that early detection is crucial, as SMA can severely impact a child's life expectancy and physical abilities.
And this is where it gets personal. Nelson's daughters, Ocean Jade and Story Monroe, exhibited symptoms like reduced leg movement and feeding difficulties. SMA affects every muscle, including those for breathing and swallowing. Without timely treatment, the disease can be fatal before a child reaches their second birthday. Thankfully, Nelson's daughters received treatment, but the prognosis includes potential disabilities.
The campaign has gained momentum, with Nelson's Instagram story sparking an outpouring of support. She aims to start a petition, urging the NHS to include SMA in the newborn screening heel prick test. The urgency is real, as the National Screening Committee is already reviewing the possibility of implementing SMA screening across the UK.
The Health Secretary, Wes Streeting, acknowledged the need for faster diagnoses and pledged to explore the use of genomic medicine. In 2021, a groundbreaking gene therapy drug, Zolgensma, was approved by the NHS to treat SMA in babies. This drug offers hope but must be administered before irreversible nerve damage occurs.
As Nelson's campaign gains traction, it raises questions: Should SMA testing be mandatory for all newborns? How can we ensure early detection and treatment for rare diseases? The debate is open, and your voice matters. Share your thoughts on this potentially life-changing initiative!
